Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Can Genetic Information Change the Clinical Care of Rheumatology Patients?

  |  Issue: February 2017  |  

Given the important potential of pharmacogenetics, Dr. Gregersen said he’d like to see it become a routine part of medical care and that every patient should have this information routinely in their charts, covering a wide variety of medications.

Mary Beth Nierengarten is a freelance medical journalist based in Minneapolis.

ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Kimmel SE, French B, Kasner SE, et al. A pharmacogenetic versus a clinical algorithm for Warfarin dosing. N Eng J Med. 2013 Dec 12;369(24):2283–2293.

Related Articles

    Shortcomings and Promises of Genome-wide Association Studies

    The outcomes of genome-wide association studies (GWAS) have not been what scientists expected, but researchers are developing new approaches to use revelatory GWAS information to identify genetic causal variants, predictors of treatment response, and future opportunities for genetic insight.

    Experts Discuss the Latest Precision Medicine Research

    SAN DIEGO—In just two decades, precision medicine has gone from futuristic concept to realistic toolbox for clinical physicians. At the 2017 ACR Clinical Research Conference on Nov. 3, the Precision Medicine in Rheumatic Diseases: Hopes and Challenges lecture featured rheumatologists and experts on genetics, genomics, pharmaco­genetics and big data who spoke about the latest research…